TACC3 and neoplasm: In conclusion, TACC3 serves as an independent prognostic biomarker, identifying high-risk patients, guiding more intensive therapeutic interventions, and correlating with tumor immune infiltration, thereby informing the selection of targeted therapies and supporting personalized, precise treatment strategies [10,52].